Table: Noile-Immune Biotech - 6-MTH parent results
Aug 8 (Reuters)-
Noile-Immune Biotech Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4 mln 2 mln
(+65.7 pct) (-77.2 pct)
Operating loss 412 mln loss 681 mln
Recurring loss 410 mln loss 682 mln
Net loss 411 mln loss 683 mln
EPS loss 9.51 yen loss 15.79 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Noile-Immune Biotech Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T